How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

712 results for

Emergency Medicine Treatment and Labor Act

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Civil Monetary Penalties Resulting From Violations of the Emergency Medical Treatment and Labor Act (EMTALA) Involving Psychiatric Emergencies, 2002 to 2018. (Abstract)

Civil Monetary Penalties Resulting From Violations of the Emergency Medical Treatment and Labor Act (EMTALA) Involving Psychiatric Emergencies, 2002 to 2018. The objective was to describe characteristics of civil monetary penalties levied by the Office of the Inspector General (OIG) related to violations of the Emergency Medical Treatment and Labor Act (EMTALA) involving psychiatric emergencies.Descriptions of EMTALA-related civil monetary penalty settlements from 2002 to 2018 were obtained (...) settlement for psychiatric-related cases was $85,488, compared with $32,004 for non-psychiatric-related cases (p < 0.001). Five (83%) of the six largest settlements during the study period were related to cases involving psychiatric emergencies. The most commonly cited deficiencies for settlements involving psychiatric patients were failure to provide appropriate medical screening examination (84%) or stabilizing treatment (68%) or arrange appropriate transfer (30%). Failure to provide stabilizing

2019 Academic Emergency Medicine

2. Emergency Medicine Treatment and Labor Act

Emergency Medicine Treatment and Labor Act Emergency Medicine Treatment and Labor Act Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Medicine Treatment and Labor Act Emergency Medicine Treatment and Labor Act Aka: Emergency Medicine Treatment and Labor Act , EMTALA From Related Chapters II. Background Emergency Medicine Treatment and Labor Act (EMTALA) was Enacted in U.S. in 1986 as part of COBRA Ensures access to emergency services regardless of ability to pay Applies to most hospitals in the United States (those that accept CMS payment) III. Criteria Includes an emergency medical screening to determine if a medical

2018 FP Notebook

3. Emergency Medicine Treatment and Labor Act

Emergency Medicine Treatment and Labor Act Emergency Medicine Treatment and Labor Act Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Medicine Treatment and Labor Act Emergency Medicine Treatment and Labor Act Aka: Emergency Medicine Treatment and Labor Act , EMTALA From Related Chapters II. Background Emergency Medicine Treatment and Labor Act (EMTALA) was Enacted in U.S. in 1986 as part of COBRA Ensures access to emergency services regardless of ability to pay Applies to most hospitals in the United States (those that accept CMS payment) III. Criteria Includes an emergency medical screening to determine if a medical

2015 FP Notebook

4. New Direct-acting Antiviral for Hepatitis C (Epclusa?

New Direct-acting Antiviral for Hepatitis C (Epclusa? MED CHECK April 2019/ Vol.5 No.13 · Page C N o 13 M ED HECK A p r i l 2 0 1 9 Accelerated Approval, Ignoring Harm, is a Crime New Direct-acting Antiviral for Hepatitis C (Epclusa ) Hemorrhage caused by an Anti-influenza Agent, Baloxavir Editorial Accelerated Approval, Ignoring Harm, is a Crime New Products New Direct-acting Antiviral for Hepatitis C (Epclusa ) Advance in hepatitis C with prior treatment failure or decompensated cirrhosis (...) for whom an anti-influenza drug should be effective. However, if you have severe flu symptoms, you may lose appetite and cannot eat. Then, you have to avoid using Xofluza due to the high risk of bleeding. After all, just like Tamiflu, Xofluza has no place in use for influenza infection. Accelerated approval, ignoring harm, is a crime.MED CHECK April 2019/ Vol.5 No.13 · Page New Direct-acting Antiviral for Hepatitis C ( Epclusa ) Advance in hepatitis C with prior treatment failure or decompensated

2019 Med Check - The Informed Prescriber

5. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

modeling and for precision medicine, because the health of the potential person represented by the source embryo is unknowable. Furthermore, most embryos used for the generation of hESCs have been left over from fertility treatments and, if implanted and taken to term normally, would not yield offspring expected to be strongly predisposed to any particular disease; however, as a result of preimplantation genetic diagnosis, in some cases the embryo is known to carry a specific, highly penetrant disease (...) Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association | Circulation: Genomic and Precision Medicine Search Hello Guest! Login to your account Email Password Keep me logged in Search February 2019 January 2019 This site uses cookies. By continuing

2018 American Heart Association

6. Cash?based approaches in humanitarian emergencies: a systematic review Full Text available with Trip Pro

Cash?based approaches in humanitarian emergencies: a systematic review Cash‐based approaches in humanitarian emergencies: a systematic review - Doocy - 2017 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access Cash‐based approaches in humanitarian emergencies: a systematic review Corresponding Author Corresponding author Shannon Doocy Johns (...) and Conditions of Use. Shareable Link Use the link below to share a full-text version of this article with your friends and colleagues. Copy URL Share a link Share on ). In addition, violent conflict affects the lives of roughly 1.5 billion people across the globe every year (World Bank, 2011). Although some crises can be directly attributed to a single, distinct event that occurs with little or no warning, most emergencies are complex, protracted and chronic, evolving from a series of related or unrelated

2017 Campbell Collaboration

7. Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use

(including antibiotics) in children, young people and adults. It aims to change prescribing practice to help slow the emergence of antimicrobial resistance and ensure that antimicrobials remain an effective treatment for infection. Who is it for? Health and social care practitioners Organisations commissioning, providing or supporting the provision of care People who are taking antimicrobials and their families and carers. Antimicrobial stewardship: systems and processes for effective antimicrobial (...) ). Page 6 of 25P Person-centred care erson-centred care This guideline offers best practice advice on the effective use of antimicrobial medicines. Patients and health professionals have rights and responsibilities as set out in the NHS Constitution for England – all NICE guidance is written to reflect these. Treatment and care should take into account individual needs and preferences. Patients should have the opportunity to make informed decisions about their care and treatment, in partnership

2015 National Institute for Health and Clinical Excellence - Clinical Guidelines

8. Immediate Postpartum Long-Acting Reversible Contraception

Immediate Postpartum Long-Acting Reversible Contraception Immediate Postpartum Long-Acting Reversible Contraception - ACOG Menu ▼ Immediate Postpartum Long-Acting Reversible Contraception Page Navigation ▼ Number 670, August 2016 (Reaffirmed 2018) Committee on Obstetric Practice The American College of Nurse–Midwives and the Society for Maternal–Fetal Medicine endorse this document. The American Academy of Family Physicians and the Association of Women’s Health, Obstetric and Neonatal Nurses (...) support this document. This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice in collaboration with committee members Ann E. Borders, MD, MSc, MPH and Alison M. Stuebe, MD, MSc, and reviewed by the Long-Acting Reversible Contraception Work Group. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course

2016 American College of Obstetricians and Gynecologists

9. i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department

decision improve. Age is a protected characteristic under the 2010 Equality Act. i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 12 of 41Evidence re Evidence review view Clinical and technical evidence Regulatory bodies Regulatory bodies A search of the Medicines and Healthcare Products Regulatory Agency website revealed (...) : 1120–4 The College of Emergency Medicine (2014) Crowding in emergency departments. Date for review: 24 June 2015 The College of Emergency Medicine (2011) Emergency department clinical quality indicators – A CEM guide to implementation. [online; accessed 5 June 2015] Thomas FO, Hoffman TL, Handrahan DL et al. (2009) The measure of treatment agreement between portable and laboratory blood gas measurements in guiding protocol-driven ventilator management. Journal of Trauma and Acute Care Surgery 67

2015 National Institute for Health and Clinical Excellence - Advice

10. Organisation and payment of emergency care services in Belgium: current situation and options for reform

beroepstitel in de up and therapeutic guidance; required actions to preserve the continuity of care to patients whether they are admitted to the hospital or not. 20 Besides other recognition standards (e.g. architecture) it is stipulated that a 24/7 hour service must be provided by at least two nurses (with at least one nurse with a ‘special title in intensive and emergency care d ’ or equal) and one physician. 21 The physician should be: a medical specialist in emergency medicine e (or in training (...) and geriatrics. 22, 23 Acute hospitals without a ‘specialised ED’ are obliged to have a non- specialised ED that is capable to deal with the first care and treatment of patients with an acute pathology. The recognition standards for non- specialised EDs are light compared to these of specialised EDs (e.g. nursing staff is not required to have a special title in emergency and intensive care; one nurse instead of two; medical 24/7 service provided by physician on call for the entire hospital). The legislator

2016 Belgian Health Care Knowledge Centre

11. Treatment of Patients with Schizophrenia

in Aggressive Behavior 138 Statement 10: Long-acting Injectable Antipsychotic Medications 140 Statement 11: Anticholinergic Medications for Acute Dystonia 146 Statement 12: Treatments for Parkinsonism 147 Statement 13: Treatments for Akathisia 147 Statement 14: VMAT2 Medications for Tardive Dyskinesia 148 Psychosocial Interventions 152 Statement 15: Coordinated Specialty Care Programs 152 Statement 16: Cognitive-behavioral Therapy 3 Statement 17: Psychoeducation 5 9 Statement 18: Supported Employment (...) Management and Recovery 52 Psychoeducation 54 Social Skills Training 58 Supported Employment 61 Supportive Therapy 65 Early Interventions for Patients With First-episode Psychosis 68 Co-occurring Substance Use and Schizophrenia 72 10 Acronyms/Abbreviations ACT Assertive community treatment AHRQ Agency for Healthcare Research and Quality AIMS Abnormal Involuntary Movement Scale APA American Psychiatric Association ANCs Absolute neutrophil counts BAP British Association for Psychopharmacology BMI Body mass

2020 American Psychiatric Association

12. Evidence-Based Clinical Guidelines for Multidisciplinary Spine Care: Diagnosis and Treatment of Low Back Pain

Society of Spine Radiology (ASSR) Medical & Psychological Treatment Section Section Chair: Christopher M. Bono, MD Authors: Paul Dougherty, DC Gazanfar Rahmathulla, MD, MBBS Christopher K. Taleghani, MD Terry Trammell, MD Randall P. Brewer, MD; Stakeholder Representative, American Academy of Pain Medicine (AAPM) Ravi Prasad, PhD; Stakeholder Representative, American Academy of Pain Medicine (AAPM) Contributor: John P. Birkedal, MD Physical Medicine & Rehabilitation Section Section Chair: Charles (...) Society (SIS) Contributors: Michael P. Dohm, MD Thomas J. Gilbert, MD Joseph Gjolaj, MD Matthew Smuck, MD, Stakeholder Representative, American Academy of Physical Medicine and Rehabilitation (AAPM&R)Diagnosis & Treatment of Low Back Pain | Preface Recommendations were developed based on a specific definition, inclusion/exclusion criteria, and the resulting literature which excluded conditions such as presence of a neurological deficit or leg pain experienced below the knee, among others. Given

2020 American Society of Regional Anesthesia and Pain Medicine

13. Diagnosis and Treatment of Low Back Pain

Treatment Section Section Chair: Christopher M. Bono, MD Authors: Paul Dougherty, DC Gazanfar Rahmathulla, MD, MBBS Christopher K. Taleghani, MD Terry Trammell, MD Randall P. Brewer, MD; Stakeholder Representative, American Academy of Pain Medicine (AAPM) Ravi Prasad, PhD; Stakeholder Representative, American Academy of Pain Medicine (AAPM) Contributor: John P. Birkedal, MD Physical Medicine & Rehabilitation Section Section Chair: Charles A. Reitman, MD Authors: R. Carter Cassidy, MD Dennis E. Enix, DC (...) . Gilbert, MD Joseph Gjolaj, MD Matthew Smuck, MD, Stakeholder Representative, American Academy of Physical Medicine and Rehabilitation (AAPM&R)Diagnosis & Treatment of Low Back Pain | Preface Recommendations were developed based on a specific definition, inclusion/exclusion criteria, and the resulting literature which excluded conditions such as presence of a neurological deficit or leg pain experienced below the knee, among others. Given the exclusion criteria, these guideline rec- ommendations

2020 North American Spine Society

14. Treatment of Fungal Infections in Adult Pulmonary, Critical Care, and Sleep Medicine: An Official ATS Statement

Treatment of Fungal Infections in Adult Pulmonary, Critical Care, and Sleep Medicine: An Official ATS Statement American Thoracic Society Documents An Of?cial American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients Andrew H. Limper, Kenneth S. Knox, George A. Sarosi, Neil M. Ampel, John E. Bennett, Antonino Catanzaro, Scott F. Davies, William E. Dismukes, Chadi A. Hage, Kieren A. Marr, Christopher H. Mody, John R. Perfect, and David (...) may emerge, medication cross-reference resources should be consulted when instituting treatment. Recommendations. In patients receiving itraconazole, vori- conazole, or posaconazole, we recommend measurements of drug levels in serum to be certain that the drug is being absorbed and to guide treatment (AII). In patients with renal insuf?ciency (creatinine clearance ,50 ml/min), we suggest reducing the dose of ?uconazole by 50% (BIII). Remark. Patients undergoing hemodialysis require redosing after

2011 American Thoracic Society

15. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value ©Institute for Clinical and Economic Review, 2018 Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value Condition Update Evidence Report June 12, 2018 Prepared for: ©Institute for Clinical and Economic Review, 2018 Page i Evidence Report: Targeted Immunomodulators for Plaque Psoriasis | Condition Update ICER Staff/Consultants (...) on the comparative clinical effectiveness and value of medical interventions. More information about New England CEPAC is available at http://icer-review.org/programs/new-england-cepac/. The findings contained within this report are current as of the date of publication. Readers should be aware that new evidence may emerge following the publication of this report that could potentially influence the results. This is an ICER update. The first report was issued in December 2016 and can be found here: https://icer

2018 California Technology Assessment Forum

16. AASLD Guidelines for Treatment of Chronic Hepatitis B

AASLD Guidelines for Treatment of Chronic Hepatitis B Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance - Terrault - 2018 - Hepatology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Practice Guidance Free Access Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance Corresponding Author E-mail (...) Consortium, Anchorage, AK Division of Gastroenterology, Corporal Michael J. Crescenz VA Medical Center & University of Pennsylvania Perelman School of Medicine, Philadelphia, PA Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY Ochsner Medical Center, New Orleans, LA

2018 American Association for the Study of Liver Diseases

17. Shoulder Conditions Diagnosis and Treatment Guideline

-arthroplasty urgently or emergently is reasonable. I. Manipulation under anesthesia/arthroscopic capsular release Manipulation under anesthesia, or arthroscopic capsular release, may be considered if a patient has persistent stiffness, typically after a procedure that has not responded to at least 12 weeks of physical therapy and/or directed home exercises. Washington State Department of Labor and Industries Medical Treatment Guideline for Shoulder Diagnosis and Treatment –updated May 2018 J. Diagnostic (...) Shoulder Conditions Diagnosis and Treatment Guideline Washington State Department of Labor and Industries Medical Treatment Guideline for Shoulder Diagnosis and Treatment –updated May 2018 Medical Treatment Guideline for Shoulder Diagnosis and Treatment Table of Contents I. Review Criteria for Shoulder Surgery 3 II. Introduction 12 III. Establishing Work-relatedness 12 A. Shoulder conditions as industrial injuries: 12 B. Shoulder conditions as occupational diseases: 13 IV. Making the Diagnosis

2018 Washington State Department of Labor and Industries

18. Calcitonin Gene-Related Peptide (CGRP) Inhibitors as Preventive Treatments for Patients with Episodic or Chronic Migraine: Effectiveness and Value

Calcitonin Gene-Related Peptide (CGRP) Inhibitors as Preventive Treatments for Patients with Episodic or Chronic Migraine: Effectiveness and Value ©Institute for Clinical and Economic Review, 2018 Calcitonin Gene-Related Peptide (CGRP) Inhibitors as Preventive Treatments for Patients with Episodic or Chronic Migraine: Effectiveness and Value Final Evidence Report July 3, 2018 Prepared for ©Institute for Clinical and Economic Review, 2018 Page ii Final Evidence Report – CGRP Inhibitors (...) are current as of the date of publication. Readers should be aware that new evidence may emerge following the publication of this report that could potentially influence the results. ICER may revisit its analyses in a formal update to this report in the future. ©Institute for Clinical and Economic Review, 2018 Page iv Final Evidence Report – CGRP Inhibitors for Episodic or Chronic Migraine In the development of this report, ICER’s researchers consulted with several clinical experts, patients

2018 California Technology Assessment Forum

19. What constitutes an effective and efficient package of services for the prevention, diagnosis, treatment and care of tuberculosis among refugees and migrants in the WHO European Region? Themed issues on migration and health

programme, Division of Health Emergencies and Communicable Diseases, WHO Regional Office for Europe Soorej J Puthoopparambil Consultant, Migration and Health programme, Division of Policy and Governance for Health and Well-being, WHO Regional Office for Europe Jon S Friedland Head of Infectious Diseases and Immunity, Imperial College London, London, United Kingdomvi vi External peer reviewers Knut Lönnroth Professor of Social Medicine, Department of Public Health Sciences, Karolinska Institutet (...) in the Region in 2016, with an estimate 71 000 cases of rifampicin-resistant/ MDR-TB. MDR-TB is difficult to treat because of its resistance to multiple first-line anti-TB medications, including the most potent ones (isoniazid and rifampicin), and presents significant challenges to the elimination of TB (3,4). Its occurrence is thought to have diverse reasons including quality of medicines, infection prevention control and the substantial driver of poor treatment completion rates, in particular

2018 WHO Health Evidence Network

20. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value ©Institute for Clinical and Economic Review, 2018 Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value Condition Update Final Evidence Report August 03, 2018 Prepared for: ©Institute for Clinical and Economic Review, 2018 Page i Final Evidence Report: Plaque Psoriasis Condition Update ICER Staff/Consultants University of Washington (...) in ICER reports and vote on the comparative clinical effectiveness and value of medical interventions. More information about New England CEPAC is available at http://icer-review.org/programs/new-england-cepac/. The findings contained within this report are current as of the date of publication. Readers should be aware that new evidence may emerge following the publication of this report that could potentially influence the results. This is an ICER update. The first report was issued in December 2016

2018 California Technology Assessment Forum

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>